Suppr超能文献

可召回且会对患者安全产生影响的药品在互联网上非法流通。

Illicit Internet availability of drugs subject to recall and patient safety consequences.

作者信息

Mackey Tim K, Aung Phyo, Liang Bryan A

机构信息

Department of Anesthesiology, University of California, San Diego School of Medicine, San Diego, CA, USA.

Division of Global Public Health, Department of Medicine, University of California, San Diego School of Medicine, San Diego, CA, USA.

出版信息

Int J Clin Pharm. 2015 Dec;37(6):1076-85. doi: 10.1007/s11096-015-0154-8. Epub 2015 Jul 7.

Abstract

BACKGROUND

Permanently recalled drugs are a public health concern if they remain accessible in violation of applicable regulation. Illicit online pharmacies act as an alternative form of access and have been associated with the sale to patients of counterfeit/falsified/fraudulent/substandard drugs. We wished to determine if permanently recalled and significantly restricted drugs were illegally marketed for sale online.

OBJECTIVE

The study was conducted in two phases with two objectives. The first phase attempted to identify drugs subject to permanent recall in certain major pharmaceutical markets as well as those listed as recalled or significantly restricted by the United Nations. We also examined the market authorization status of identified drugs in China and India. The second phase used structured searches on the Internet to determine if identified drugs were marketed for sale online.

SETTING

The World Wide Web.

METHOD

After identification of permanently recalled and restricted drugs we conducted Internet searches for illegal "no prescription" marketing events. We assessed the form of marketing, whether a site offered direct-to-patient sale, use of social media marketing, and the site's compliance status with external monitoring bodies.

MAIN OUTCOME

Number of recalled drugs marketed as available for purchase on the Internet.

RESULTS

We identified 16 class I equivalent permanently recalled or restricted drugs, 56.3 % (n = 9) of which maintained market authorization in either China or India. Half (n = 8) were marketed for sale online without a prescription direct-to-patient. Use of social media marketing was mixed, with only 18.8 % (n = 3) of recalled drugs having a presence on Facebook, though 50.0 % (n = 8) had content on Twitter. We also found the majority (68.8 %, n = 11) were available and marketed for sale by vendors on the wholesale/business-to-business website alibaba.com primarily as active pharmaceutical ingredient.

CONCLUSION

Despite efforts in several countries to restrict access to these drugs or permanently remove them from the market, our study indicates that various sources actively market recalled drugs for sale online. Drug regulators, public health agencies, and law enforcement officials should act with urgency to appropriately restrict and regulate these sales to protect global patients and consumers.

摘要

背景

如果永久召回的药品违反适用规定仍可获取,就会成为公共卫生问题。非法在线药店成为获取药品的另一种途径,且与向患者销售假冒/伪造/欺诈/不合格药品有关。我们希望确定永久召回和严格限制的药品是否在网上非法销售。

目的

该研究分两个阶段进行,有两个目标。第一阶段试图确定在某些主要药品市场被永久召回的药品以及被联合国列为召回或严格限制的药品。我们还研究了这些药品在中国和印度的市场授权状况。第二阶段通过在互联网上进行结构化搜索,以确定这些药品是否在网上销售。

地点

万维网。

方法

在确定永久召回和受限药品后,我们在互联网上搜索非法的“无需处方”销售情况。我们评估了销售形式,即网站是否提供直接面向患者的销售、社交媒体营销的使用情况以及网站与外部监管机构的合规状况。

主要结果

在互联网上作为可购买药品销售的召回药品数量。

结果

我们确定了16种相当于一级永久召回或受限的药品,其中56.3%(n = 9)在中国或印度仍保有市场授权。一半(n = 8)的药品在网上无处方直接面向患者销售。社交媒体营销的使用情况不一,只有18.8%(n = 3)的召回药品在脸书上有相关内容,不过50.0%(n = 8)在推特上有相关内容。我们还发现,大多数(68.8%,n = 11)药品可在批发/企业对企业网站阿里巴巴上由供应商作为活性药物成分销售。

结论

尽管多个国家努力限制获取这些药品或将其永久退市,但我们的研究表明,各种渠道仍在积极在网上销售召回药品。药品监管机构、公共卫生机构和执法官员应紧急采取行动,适当限制和规范这些销售行为,以保护全球患者和消费者。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验